Hans-Leo Teulings is founder and CEO of NeuroScript, the leading company in handwriting movement software. The company started in 1997 after receiving its first Phase 1 Innovation Research (SBIR) grant from the US National Institutes of Health (NIH). Until 2008 10 Phase 1 and 2 grants were awarded totaling $4.2M. His interest is to provide tools to accelerate research and application development in all fields where fine motor control of handwriting, the most trained motor skill we know, plays a role: neurology, psychiatry, novel pharmacological drug development, psychology, physiotherapy, education, forensics, and computer science. His education includes a MSc in experimental physics and biophysics received in 1975 and a PhD in experimental psychology received in 1988 from the Radboud University of Nijmegen (The Netherlands). He was visiting researcher at the universities of Cambridge (UK), Trondheim (Norway), Genoa (Italy), Madison (Wisconsin, USA), and Tempe (Arizona, USA).